Full-year instruments revenue fell 39% year-over-year while consumables grew 3%, highlighting a key challenge as the company navigates a strategic product transition. Wall Street expects a ...
PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $16.3 million in its fourth quarter.
StockStory.org on MSN
10x Genomics (NASDAQ:TXG) delivers impressive Q4 CY2025
Biotech company 10x Genomics (NASDAQ:TXG) reported in Q4 CY2025, but sales were flat year on year at $166 million. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results